Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy.

MLA

Lu, Ge, et al. “Combination of Bone Marrow Mesenchymal Stem Cells and Moxibustion Restores Cyclophosphamide-Induced Premature Ovarian Insufficiency by Improving Mitochondrial Function and Regulating Mitophagy.” Stem Cell Research & Therapy, vol. 15, no. 1, Apr. 2024, p. 102. EBSCOhost, https://doi.org/10.1186/s13287-024-03709-0.

APA

Lu, G., Li, H.-X., Song, Z.-W., Luo, J., Fan, Y.-L., Yin, Y.-L., Shen, J., & Shen, M.-H. (2024). Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy. Stem Cell Research & Therapy, 15(1), 102. https://doi.org/10.1186/s13287-024-03709-0

Chicago

Lu, Ge, Hong-Xiao Li, Zi-Wei Song, Jia Luo, Yan-Liang Fan, Yao-Li Yin, Jie Shen, and Mei-Hong Shen. 2024. “Combination of Bone Marrow Mesenchymal Stem Cells and Moxibustion Restores Cyclophosphamide-Induced Premature Ovarian Insufficiency by Improving Mitochondrial Function and Regulating Mitophagy.” Stem Cell Research & Therapy 15 (1): 102. doi:10.1186/s13287-024-03709-0.